أعرض في EDS

1082MO 5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO+IPI) or NIVO alone

التفاصيل البيبلوغرافية
العنوان: 1082MO 5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO+IPI) or NIVO alone
المؤلفون: F.S. Hodi, Kenneth F. Grossmann, Céleste Lebbé, Jason Chesney, John Wagstaff, Sandra Re, J.M.G. Larkin, Jessica C. Hassel, Anna C. Pavlick, Georgina V. Long, P.A. Ascierto, C. Robert, Ivan Marquez-Rodas, Jedd D. Wolchok, Marcus O. Butler, W. van Dijck, Michael A. Postow, Oliver Bechter, Dirk Schadendorf, J.-J. Grob
المصدر: Annals of Oncology. 31:S734-S735
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, In patient, Ipilimumab, Hematology, Nivolumab, business, Advanced melanoma, medicine.drug
تدمد: 0923-7534
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::49fbd141fb460af07a1bd872c8943853Test
https://doi.org/10.1016/j.annonc.2020.08.1206Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........49fbd141fb460af07a1bd872c8943853
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534